Chapter title |
Nonhuman Primate Models for Nipah and Hendra Virus Countermeasure Evaluation.
|
---|---|
Book title |
Nipah Virus
|
Published in |
Methods in molecular biology, January 2023
|
DOI | 10.1007/978-1-0716-3283-3_12 |
Pubmed ID | |
Book ISBNs |
978-1-07-163282-6, 978-1-07-163283-3
|
Authors |
Mire, Chad E, Satterfield, Benjamin A, Geisbert, Thomas W, Mire, Chad E., Satterfield, Benjamin A., Geisbert, Thomas W. |
Abstract |
Hendra and Nipah viruses are henipaviruses that have caused lethal human disease in Australia and Malaysia, Bangladesh, India, and the Philippines, respectively. These viruses are considered Category C pathogens by the US Centers for Disease Control. Nipah virus was recently placed on the World Health Organization Research and Development Blueprint Roadmaps for vaccine and therapeutic development. Given the infrequent and unpredictable nature of henipavirus outbreaks licensure of vaccines and therapeutics will likely require an animal model to demonstrate protective efficacy against henipavirus disease. Studies have shown that nonhuman primates are the most accurate model of human henipavirus disease and would be an important component of any application for licensure of a vaccine or antiviral drug under the US FDA Animal Rule. Nonhuman primate model selection and dosing are discussed regarding vaccine and therapeutic studies against henipaviruses. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 6 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 3 | 50% |
Unspecified | 1 | 17% |
Unknown | 2 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Unspecified | 1 | 17% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 17% |
Biochemistry, Genetics and Molecular Biology | 1 | 17% |
Medicine and Dentistry | 1 | 17% |
Unknown | 2 | 33% |